<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "chlorambucil tab>
<dose><value>0.5</value>
<value>6</value>
<value>0.15</value>
<value>0.1</value>
<value>0.2</value>
</dose><route><value>PO</value>
</route><form><value>tab</value>
</form><drugname><value>chlorambucil tab</value>
</drugname><strength><value>2 mg</value>
</strength><frequency><value>EVERY 2 WEEKS</value>
<value>DAILY</value>
</frequency><instruction><value>for 2 doses (DAY 1 &amp; 15). </value>
<value>for 14 days.</value>
<value></value>
</instruction><volume><value></value>
</volume><units><value>mg/kg</value>
<value>mg/m2</value>
<value>mg/kg/day</value>
</units><additionalnotes><value>Chronic Lymphocytic Leukemia. Round dose to nearest 2 mg. Recommend dosage reduction if CrCl 10 to 50 mL/minute: 75% of dose, CrCl less than 10 mL/minute: 50% of dose.</value>
<value>Hodgkin&amp;apos;s Lymphoma. Maximum dose: 10 mg.Recommend dosage reduction if CrCl is 10 to 50 mL/minute: 75% of dose, CrCl less than 10 mL/minute: 50% of dose.</value>
<value>Chronic Lymphocytic Leukemia. Treat until WBC is 10,000/mm3, interrupt treatment for 4 weeks. Then resume at 0.1 mg/kg/day. Recommend dosage reduction if CrCl10 to 50 mL/minute: 75% of dose, CrCl less than 10 mL/minute: 50% of dose.</value>
<value>Hodgkin Lymphoma. Treatment 4 to 8 weeks. Recommend dosage reduction if CrCl 10 to 50 mL/minute: 75% of dose, CrCl less than 10 mL/minute: 50% of dose.</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3355</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>